{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:05:07Z","timestamp":1765803907415,"version":"3.48.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sterile pyuria is a common manifestation of Kawasaki disease (KD). We investigated the characteristics of KD patients with sterile pyuria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study included 345 KD patients who had not received antimicrobial therapy before the diagnosis. These patients were divided into 2 groups based on the presence or absence of sterile pyuria, and the clinical characteristics were compared between the 2 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 345 patients, 151 (43.8%) had sterile pyuria. The peripheral neutrophil counts and serum levels of aspartate aminotransferase and C-reactive protein were significantly higher in KD patients with sterile pyuria than in those without sterile pyuria (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001, respectively). The serum sodium levels were significantly lower in the patients with sterile pyuria (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The proportion of KD patients that were resistant to initial high-dose intravenous immunoglobulin (IVIG) therapy was significantly higher in the patients with sterile pyuria (26.5%) than in those without sterile pyuria (10.8%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). There was no significant difference in the incidence of coronary artery abnormalities between the 2 groups. In the prediction of the patients who were resistant to initial IVIG therapy, the sensitivity of positivity for sterile pyuria (66%) was superior to that of the Gunma score (52%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>KD patients with sterile pyuria are likely to be resistant to initial IVIG therapy. Performing examinations of sterile pyuria may be useful to complement the scoring systems to predict the patients who may be resistant to initial IVIG therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004988","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:02:43Z","timestamp":1757509363000},"page":"36-39","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Clinical Characteristics of Kawasaki Disease Patients With Sterile Pyuria"],"prefix":"10.1097","volume":"45","author":[{"given":"Miku","family":"Shono","sequence":"first","affiliation":[{"name":"General Medical Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenpei","family":"Kano","sequence":"additional","affiliation":[{"name":"General Medical Department"},{"name":"Kawasaki Disease Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Tanaka","sequence":"additional","affiliation":[{"name":"General Medical Department"},{"name":"Kawasaki Disease Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kuga","sequence":"additional","affiliation":[{"name":"General Medical Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"General Medical Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Torio","sequence":"additional","affiliation":[{"name":"General Medical Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Harada","sequence":"additional","affiliation":[{"name":"Kawasaki Disease Center"},{"name":"Department of Pediatric Infectious Diseases and Immunology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kanemasa","sequence":"additional","affiliation":[{"name":"Kawasaki Disease Center"},{"name":"Department of Pediatric Infectious Diseases and Immunology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagano","family":"Onoyama","sequence":"additional","affiliation":[{"name":"Kawasaki Disease Center"},{"name":"Department of Pediatric Infectious Diseases and Immunology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8005-0072","authenticated-orcid":false,"given":"Takayuki","family":"Hoshina","sequence":"additional","affiliation":[{"name":"General Medical Department"},{"name":"Kawasaki Disease Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 Guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease.","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamapediatrics.2022.3756","article-title":"Incidence of Kawasaki disease before and after the COVID-19 pandemic in Japan: results of the 26th nationwide survey, 2019 to 2020.","volume":"176","author":"Ae","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.","volume":"166","author":"Sano","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5409\/wjcp.v4.i2.25","article-title":"Pyuria in patients with Kawasaki disease.","volume":"4","author":"Watanabe","year":"2015","journal-title":"World J Clin Pediatr"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00467-007-0449-7","article-title":"Sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney.","volume":"22","author":"Watanabe","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3345\/kjp.2013.56.1.13","article-title":"Clinical characteristics of Kawasaki disease with sterile pyuria.","volume":"56","author":"Choi","year":"2013","journal-title":"Korean J Pediatr"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"856144","DOI":"10.3389\/fcvm.2022.856144","article-title":"Sterile pyuria in Kawasaki disease: a large prospective cohort study.","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr Int"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(78)81078-6","article-title":"Urinary lactic dehydrogenase isoenzyme IV and V in the differential diagnosis of cystitis and pyelonephritis.","volume":"93","author":"Devaskar","year":"1978","journal-title":"J Pediatr"},{"key":"R14-20251215","first-page":"962","article-title":"Urinary lactic dehydrogenase activity. I. Screening method for detection of cancer of kidneys and bladder.","volume":"181","author":"Wacker","year":"1962","journal-title":"JAMA"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"4162597","DOI":"10.1155\/2017\/4162597","article-title":"Urinary lactate dehydrogenase activity and its isozyme patterns in Kawasaki disease.","volume":"2017","author":"Kawamura","year":"2017","journal-title":"Int J Pediatr"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3109\/14397595.2015.1038430","article-title":"Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.","volume":"25","author":"Yamamoto","year":"2015","journal-title":"Mod Rheumatol"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.","volume":"158","author":"Sleeper","year":"2011","journal-title":"J Pediatr"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"e2022059175","DOI":"10.1542\/peds.2022-059175","article-title":"Prediction models for intravenous immunoglobulin resistance in Kawasaki Disease: a meta-analysis.","volume":"151","author":"Kuniyoshi","year":"2023","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:01:08Z","timestamp":1765803668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004988","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"type":"print","value":"0891-3668"},{"type":"electronic","value":"1532-0987"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}